Error loading player: No playable sources found
5210
Innovations in Early Detection of Pancreatic Cancer
Date
May 21, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Full DDW 2024 On Demand Program available now!
SOCIETY: AGA A translational symposium that focuses on the evolving role of artificial intelligence and machine learning in early detection of pancreatic cancer, genetic testing and novel molecular diagnostic bio-markers and recent advances in digital tools that can be applied to enhance early detection and improve care of high-risk individuals.
Moderators
Massachusetts General Hospital
Cedars-Sinai Medical Center
General
Tracks
Related Products
Clinical Acute Pancreatitis
SOCIETY: AGA
Painful Chronic Pancreatitis: Are We Improving Outcomes?
Review the current medical, endoscopic and surgical approaches to treating pain in chronic pancreatitis. Learn why current interventions are not leading to the anticipated pain response…
Emerging Tests for Screening/Early Detection of GI (and other) Cancers
SOCIETY: AGA Session will review emerging technologies and biomarker assays for detection of gastrointestinal neoplasia…
